RPBio Inc.

KO:314140 Korea
Market Cap
$45.05K
₩65.96 Million KRW
Market Cap Rank
#42657 Global
#2379 in Korea
Share Price
₩6600.00
Change (1 day)
+0.00%
52-Week Range
₩4850.00 - ₩8010.00
All Time High
₩18189.89
About

RPBio Inc. operates in various business sectors.

Market Cap & Net Worth: RPBio Inc. (314140)

RPBio Inc. (KO:314140) has a market capitalization of $45.05K (₩65.96 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #42657 globally and #2379 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying RPBio Inc.'s stock price ₩6600.00 by its total outstanding shares 9994 (9.99K).

RPBio Inc. Market Cap History: 2022 to 2026

RPBio Inc.'s market capitalization history from 2022 to 2026. Data shows change from $85.15K to $45.05K (-25.36% CAGR).

RPBio Inc. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how RPBio Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 314140 by Market Capitalization

Companies near RPBio Inc. in the global market cap rankings as of March 18, 2026.

Key companies related to RPBio Inc. by market ranking:

  • Perk Labs Inc (PINK:PKLBF): Ranked #42648 globally with a market cap of $41.63K USD.
  • Egyptian Financial & Industrial (EGX:EFIC): Ranked #42649 globally with a market cap of $41.61K USD ( EGP2.10 Million EGP).
  • Erlebnis Akademie AG (DU:EAD): Ranked #42658 globally with a market cap of $41.38K USD ( €40.31K EUR).
  • TELIA COMPANY (TLS.SG) (STU:TLS): Ranked #42659 globally with a market cap of $41.37K USD ( €40.30K EUR).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#42648 Perk Labs Inc PINK:PKLBF $41.63K $0.00
#42649 Egyptian Financial & Industrial EGX:EFIC $41.61K EGP219.16
#42658 Erlebnis Akademie AG DU:EAD $41.38K €4.08
#42659 TELIA COMPANY (TLS.SG) STU:TLS $41.37K €4.32

RPBio Inc. Historical Marketcap From 2022 to 2026

Between 2022 and today, RPBio Inc.'s market cap moved from $85.15K to $ 45.05K, with a yearly change of -25.36%.

Year Market Cap Change (%)
2026 ₩45.05K -10.81%
2025 ₩50.51K +46.53%
2024 ₩34.47K -41.62%
2023 ₩59.04K -30.66%
2022 ₩85.15K --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of RPBio Inc. was reported to be:

Source Market Cap
Yahoo Finance $45.05K USD
MoneyControl $45.05K USD
MarketWatch $45.05K USD
marketcap.company $45.05K USD
Reuters $45.05K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.